Clinical trial

Pemetrexed Plus Cisplatin for Brain Metastasis of Advanced Non - Small Cell Lung Cancer (NSCLC)

NCT00744900

Study summary

ClinicalTrials.gov

Pemetrexed Plus Cisplatin for Brain Metastasis of Advanced Non - Small Cell Lung Cancer (NSCLC)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Pemetrexed, cisplatin Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-09-01

PhasePHASE2

Conditions

Lung Cancerverified · MONDO: lung cancer

Interventions

Pemetrexed, cisplatinDRUG

Sponsors & collaborators

University Hospital, Brestlead sponsor

Mapped research locations

RouenFrance2 ParisFrance1 ToulouseFrance1 MarseilleFrance1 LyonFrance1 RennesFrance1 CaenFrance1 BrestFrance1 AngersFrance1 CréteilFrance1 Pierre-BéniteFrance1 La Roche-sur-YonFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00744900 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.